The Lancet Neurology: Post-concussion 'Return to Play' Decision for Footballers Should Be Made Solely by Doctors, Says New Editorial
Published: July 13, 2014.
Released by The Lancet
An editorial published today in The Lancet Neurology calls for sports authorities to take into consideration the long term neurological problems that repeated concussions can cause. Cerebral concussion is the most common form of sports-related traumatic brain injury (TBI), and the long-term effects of repeated concussions may include dementia, amyotrophic lateral sclerosis, and other neurological disorders, say the journal editors.
Full Story »
More news from The Lancet
The Lancet Neurology: Autism Series Media Alert
The Lancet Neurology journal is pleased to announce that the following papers will be published as part of a Series on autism spectrum disorder, ahead of the 2015 Annual Meeting of the American Academy of Neurology: Gene hunting in autism spectrum disorder: on the path to precision medicine [Embargo: 6:30pm [New York time] Thursday 16 April, 2015]
The Lancet Diabetes & Endocrinology: Being Underweight in Middle Age Associated with Increased Dementia Risk
Middle-aged people who are underweight (with a Body Mass Index [BMI] less than 20 kg/m2 ) are a third more likely to develop dementia than people of similar age with a healthy BMI, according to new research published in The Lancet Diabetes & Endocrinology journal.
The Lancet: Phase 1 Trial of First Ebola Vaccine Based on 2014 Virus Strain Shows Vaccine Is Safe And Provokes an Immune Response
Results from the first phase 1 trial of an Ebola vaccine based on the current (2014) strain of the virus are today published in The Lancet. Until now, all tested Ebola virus vaccines have been based on the virus strain from the Zaire outbreak in 1976. The results suggest that the new vaccine is safe, and provokes an immune response in recipients, although further long-term testing will be needed to establish whether it can protect against the Ebola virus.
The Lancet: WHO's New End TB Strategy
On May 19, 2014, the 67th World Health Assembly (WHA) adopted WHO's "Global strategy and targets for tuberculosis prevention, care and control after 2015". This post-2015 global tuberculosis strategy, labelled the End TB Strategy, was shaped during the past 2 years. A wide range of stakeholders--from ministries of health and national tuberculosis programmes to technical and scientific institutions, financial and development partners, civil society and health activists, non-governmental organisations, and the private sector--contributed to its development. The strategy has a vision of making
Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in Children: A Systematic Review And Meta-analysis
Microbiological confirmation of childhood tuberculosis is rare because of the difficulty of collection of specimens, low sensitivity of smear microscopy, and poor access to culture. This study, led by Dr Anne Detjen, from the International Union Against Tuberculosis and Lung Disease, aimed to establish summary estimates for sensitivity and specificity of the Xpert MTB/RIF assay compared with microscopy in the diagnosis of pulmonary tuberculosis in children. The researchers found that compared with microscopy, Xpert offers better sensitivity for the diagnosis of pulmonary tuberculosis
The Lancet Infectious Diseases: Experts Warn of Potential Upsurge in Mosquito And Tick-borne Diseases as UK Climate Gets Warmer
Climate change could accelerate the emergence of vector-borne diseases such as chikungunya, dengue fever, and West Nile virus in the UK, warn leading public health experts Dr Jolyon Medlock and Professor Steve Leach from the Emergency Response Department at Public Health England, writing in The Lancet Infectious Diseases journal.
The Lancet: More Than 2 Million People Die Prematurely Every Year Because Treatment for Kidney Failure Is Unavailable
New estimates published in The Lancet indicate that at best only half of people worldwide needing kidney dialysis or transplantation to treat kidney failure in 2010 received it. This suggests that at least 2.3 million people may have died prematurely from kidney failure because they could not access this life-saving treatment.
The Lancet: International Experts Call for an End to Preventable Deaths from Acute Kidney Injury by 2025
Preventable deaths caused by acute kidney injury (AKI) could be nearly eliminated in just 10 years, according to leading medical experts. This often forgotten condition - which affects around 13 million people every year and contributes to 1.7 million deaths annually - is preventable and can be treated for as little as $US150 per patient.